David A. Siegel Celldex Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $507,168 - $747,072	14,400 New	14,400 $604,000
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $1.06 Million - $1.44 Million	-30,400 Reduced 45.65%	36,200 $1.3 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $1.49 Million - $2.43 Million	-53,500 Reduced 44.55%	66,600 $2.97 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $2.49 Million - $4.13 Million	-109,800 Reduced 47.76%	120,100 $3.38 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $2.49 Million - $4.13 Million	-109,800 Reduced 47.76%	120,100 $3.38 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $1.56 Million - $2.83 Million	75,900 Added 49.29%	229,900 $6.2 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $2.59 Million - $3.68 Million	93,700 Added 155.39%	154,000 $5.25 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $2.15 Million - $3.39 Million	60,300 New	60,300 $2.33 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $2.54 Million - $4.91 Million	-87,736 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $2.54 Million - $4.33 Million	-122,520 Reduced 58.27%	87,736 $2.93 Million
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $3.1 Million - $5.72 Million	-191,300 Reduced 47.64%	210,256 $4.33 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $626,582 - $950,950	-41,800 Reduced 9.43%	401,556 $7.04 Million
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $3.74 Million - $5.88 Million	387,300 Added 690.92%	443,356 $6.58 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $90,250 - $751,710	56,056 New	56,056 $729,000
Q1 2020 May 15, 2020	SELL	$1.55 - $3.07 $25,570 - $50,645	-16,497 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.11 - $2.8 $8,229 - $10,920	-3,900 Reduced 19.12%	16,497 $37,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.75 $13,529 - $18,150	-6,600 Reduced 24.45%	20,397 $43,000
Q2 2019 Aug 14, 2019	SELL	$2.43 - $5.09 $7,047 - $14,761	-2,900 Reduced 9.7%	26,997 $72,000
Q1 2019 May 15, 2019	BUY	$3.45 - $10.35 $103,144 - $309,433	29,897 New	29,897 $147,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

Wellington Management Group LLP Boston, MA

9.24M
Shares

$241 Million
0.06% of portfolio
Black Rock Inc. New York, NY

4.69M
Shares

$122 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.87M
Shares

$101 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

3.46M
Shares

$90.1 Million
9.64% of portfolio
Eventide Asset Management, LLC Boston, MA

3.33M
Shares

$86.8 Million
1.99% of portfolio

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account